Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ALLO — Allogene Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 14, 2026
REVENUE
$0
EPS
-$0.18 -5.9%
FREE CASH FLOW
-$12.9M +53.2%

No summary has been written for this call yet.